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1. Background information 
1.1 Introduction to vertigo and dizziness 
Vertigo and dizziness are among the most common complaints dealt with by 
primary care practices (Mueller, Strobl et al. 2013, Grill, Strupp et al. 2014), referral 
practices (Neuhauser, Radtke et al. 2008, Benecke, Agus et al. 2013) and emergency 
departments (Kerber, Meurer et al. 2008, Post and Dickerson 2010). The terms vertigo 
and dizziness are used to describe a variety of sensations, such as unsteadiness and 
light-headedness and may be the symptoms many pathological or physiological 
processes (Brandt 2013).  
Generally three main forms of vertigo, namely, peripheral vestibular, central 
vestibular, and non-vestibular forms can be differentiated (Mathieson, Darlington et al. 
1999). The most common peripheral diagnosis is benign paroxysmal positioning 
vertigo (BPPV), found to be prevalent in 9% of the general population (Kerrigan, 
Costigan et al. 2013) and 17.1% of the patients of a specialized tertiary vertigo clinic 
(Strupp, Dieterich et al. 2013). Central vestibular vertigo is caused by the dysfunction 
or injury of the central nervous system (CNS), such as multiple sclerosis, migraines, 
and acoustic neuromas (Foris and Dulebohn 2018). Other possible causes such as 
mental disorders and side effects from medications can lead to non-vestibular vertigo. 
Figure 1 (data from the German Centre for Vertigo and Balance Disorders (Strupp, 
Dieterich et al. 2013)) shows the frequency of diagnostic classifications amongst 
17,718 vertigo patients of a dedicated tertiary care facility .  
Finding the potential risk factors could be beneficial for preventing and controlling 
the disease. Being female significantly increases the risk of having dizziness (Bisdorff, 
Bosser et al. 2013, Grill, Müller et al. 2013) for both older (Kerrigan, Costigan et al. 
2013) and young populations (Humphriss and Hall 2011). Some forms of vertigo such 
as BPPV (Ferrari, Monzani et al. 2014, Yetiser and Ince 2015) and Meniere’s (Havia, 
Kentala et al. 2005, Harris and Alexander 2010) are more frequent in women. Another 
widely documented risk factor is age. Many studies (Maarsingh, Dros et al. 2010, 
Fernández, Breinbauer et al. 2015, Neuhauser 2016) have shown that older adults are 
particularly likely to suffer from dizziness. Apart from these, consumption of 
anticonvulsant, anti-hypertensive drugs (Chimirri, Aiello et al. 2013), as well as 
sedatives and cholesterol-reducing drugs, (Tamber and Bruusgaard 2009) can also 
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increase the risk of experiencing dizziness. Dizziness is also associated with particular 
psychiatric disorders, especially depression and anxiety (Wiltink, Tschan et al. 2009, 
Kozak, Dündar et al. 2018, Wei, Sayyid et al. 2018).  
 
1.2 The burden of vertigo and dizziness  
Burden of disease (BOD) is a concept that was developed in the 1990s (Mathers, 
Lopez et al. 2006). It is a comprehensive approach to assess the overall impact of 
disease, injury, and risk factors on society and the state across all regions globally 
(Murray, Ezzati et al. 2012), by using indicators such as prevalence, mortality, 
morbidity, disability adjusted life years (DALY), and quality adjusted life years (QALY) 
to quantify the population health losses. The most important and comprehensive disease 
burden research program is the Global Burden of Diseases, Injuries, and Risk Factors 
(GBD) study sponsored by the World Bank and World Health Organisation (WHO).  
Much research has been conducted to assess the burden of vertigo and dizziness 
from different epidemiological perspectives (Neuhauser, Radtke et al. 2008, Lempert 
17.1%
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12.3%
11.4%
10.1%
8.3%
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3.7%
2.9%
1%
2.7%
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Benign paroxysmal positional vertigo
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Psychogenic vertigo (other)
Perilymphatic fistula
Vertigo of unknown origin
Other*
Figure 1: The frequencies of different diagnoses of 17718 dizziness patients, data from the German Center 
for Vertigo and Balance Disorders. 
* Includes, among others, nonvestibular vertigo in neurodegenerative diseases, nonvestibular oculomotor 
disorders in myasthenia gravis, and peripheral ocular muscle paresis 
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and Neuhauser 2009, Holmes and Padgham 2011, Lai, Wang et al. 2011, Bittar, Oiticica 
et al. 2013, Wojtczak, Narożny et al. 2017). Due to the high heterogeneity of studied 
populations, report duration, and disease definition, the one-year prevalence of vertigo 
and dizziness in the general adult population has been found to range from 3.1% in 
Taiwan (Lai, Wang et al. 2011), 7% in Germany (Lempert and Neuhauser 2009), 16.4% 
in Poland (Wojtczak, Narożny et al. 2017) to 42% in Brazil (Bittar, Oiticica et al. 2013). 
By contrast, studies examining one-year incidence have found similar figures across 
different studies, ranging from 1.4% (Neuhauser, Von Brevern et al. 2005, Neuhauser, 
Radtke et al. 2008, Lempert and Neuhauser 2009) to 3.1% (Neuhauser 2016). 
Other than prevalence and incidence, quality of life (QoL) is also an important 
indicator of the burden of disease. There is considerable evidence which demonstrates 
that dizziness is associated with falling (Alyono 2018), disability(Lasisi and Gureje 
2010, Mueller, Strobl et al. 2013) , daily life restriction (Tinetti, Williams et al. 2000, 
Karatas 2008), emotional problems (Karatas 2008, Chang, Hwang et al. 2017), and thus 
leads to a poor quality of life (Lopez-Escamez, Gamiz et al. 2005, Neuhauser, Radtke 
et al. 2006, Aratani, Perracini et al. 2011). 
Furthermore, dizziness has a notable negative impact on work productivity 
(Yardley, Owen et al. 1998, Bronstein, Golding et al. 2010). Studies have shown that in 
12% of cases orthostatic dizziness was associated with sick leave days (Radtke, 
Lempert et al. 2011), and 50% of cases reported reduced efficiency (Bronstein, Golding 
et al. 2010). Thus, dizziness resulted in an economic loss for both individual workers 
and wider society loss which cannot be ignored. 
1.3 The economic burden of vertigo and dizziness 
The findings of BOD studies can provide benefits to governments and health care 
systems for guiding the allocation of resources according to disease and risk priorities 
(Hoy, March et al. 2010). However, it should be noted that the design of BOD studies 
focuses only on the fact of losses in health and quality of life, and therefore do not 
present a comprehensive economic description of the impact on individual income, or 
the productivity losses for society as a whole (Murray, Ezzati et al. 2012).  
To assess the economic burden of disease, cost of illness (COI) studies are widely 
used to identify and measure the direct and indirect cost of disease (Rice 2000, Larg 
and Moss 2011). Direct cost, indirect cost and the intangible costs of disease are usually 
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considered in such calculations in order to make an accurate estimate. Direct costs 
include all the health care expenditures associated with diagnosis, treatment, and the 
rehabilitation process. Indirect costs of disease reflect the productivity loss. Intangible 
costs refer to the pain and sufferings associated with illness, which are hard to measure 
or transfer into monetary results, and therefore are only conduct by a few COI studies 
(Tarricone 2006, Xie, Thumboo et al. 2008). 
By applying a COI study, we cannot only describe the total costs concisely, but also 
identify the individual characteristics that could influence health care utilization and 
expenditure. A widely used model is taken from Andersen’s study (Andersen and 
Newman 1973), which divides factors that might affect health care utilization into three 
domains: predisposing, enabling, and need factors. Within the research of a particular 
disease, a comprehensive examination of these influence factors would allow policy 
makers and health care payers to optimize resource allocation and control the escalation 
of health care cost. Therefore, COI studies are regarded as useful and important 
supplementary evidence to BOD studies (Byford, Torgerson et al. 2000).  
However, when searching the literature, it can be easily found that even though 
numerous studies have pointed out that the presence of vertigo and dizziness directly 
consumed extensive amount of health care utilization due to its diagnostic and treatment 
process (Wiltink, Tschan et al. 2009, Lai, Wang et al. 2011, Radtke, Lempert et al. 2011, 
Li, Hoffman et al. 2016), as well as the social economic burden caused by related 
disability, retirement and sick leave (Neuhauser, Radtke et al. 2008, Mueller, Schuster 
et al. 2012, Mueller, Strobl et al. 2013, Lüscher, Theilgaard et al. 2014), there is only 
limited evidence on the economic burden of vertigo.  
Up to now, the direct and indirect cost of vertigo and dizziness have not been 
systematically assessed and thus the economic burden related to vertigo and dizziness 
is still unclear. Also, determinants of health expenditure due to vertigo are poorly 
understood. 
 
2. Research objectives 
The overall aim of this doctoral thesis is to evaluate the economic burden of vertigo 
and dizziness among adults. To address this problem, the following research questions 
will be studied:  
1) What kind of existing economic evidence can be found from previous studies? 
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What is already known about the cost of vertigo and dizziness? 
2) For the general population, what is the total cost of vertigo? Are there health care 
costs or utilization differences between people with and without vertigo? What 
individual factors could affect the health care cost of vertigo? 
Therefore, this doctoral thesis was divided into two parts.  
a) To answer question 1, a systematic review was conducted, and the existing 
evidence was summarized and described. 
b) To answer question 2, a cost of illness analysis was performed using cross sectional 
data from the German Cooperative Health Research in the Augsburg Region 
(KORA) cohort to quantify the utilization and cost of health care associated with 
vertigo. Direct and indirect health care utilization data was collected, total cost was 
calculated and compared between vertigo patients and a control group. 
 
3. Method 
To address the two research questions described in the previous chapter, two studies 
were conducted and published. They build the core of this doctoral thesis. The methods 
selected in these two publications are summaries and listed as below.  
3.1 Publication 1: Economic burden of vertigo. A systematic review 
We conducted an extensive systematic literature search on 01 October 2018. The 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 
statement)(Moher, Liberati et al. 2009) were followed for the organization of the 
review. Three different electronic databases were searched, namely: Medline 
(https://www.ncbi.nlm.nih.gov/pubmed ), EMBASE 
(https://www.sciencedirect.com/science/search ) and Cochrane 
(http://onlinelibrary.wiley.com/cochranelibrary/search/ ). All original studies 
published in English between 2008-2018 about the economic evaluation of vertigo in 
developed countries were considered as eligible. Based on the diagnosis 
classifications of disease (Brandt, Dieterich et al. 2005, Strupp and Brandt 2008), a 
search strategy was developed using terms including “BPPV”, “Meniere”, “vestib*”, 
“labyrinthitis", “dizz*”, “vertigo” and “dizziness”. Terms like “cost”, “financ*”, 
“econom*”, “burden”, “utilization or utilisation” and “pay*” were used to target 
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disease cost information. 
For data extraction, a Microsoft Excel form was built to obtain variables, 
referring to general study characteristics and outcome items. Two independent 
reviewers checked the papers after the literature collection; in lack of consensus, a  
third made the decision. 
The doctoral candidate was the second author of this article. She was primarily 
responsible for paper collection, data extraction and study selection with the guidance 
of the first author, Dr. Eva Kovacs. Together with the first author, the doctoral 
candidate finished the systematic analysis and preparation of the manuscript. The 
article was submitted to Health Economics Review on 06 March 2019 and accepted 
for publication after revision on 25 October 2019. The impact factor of the journal 
was 1.374 in the year of 2019. 
3.2 Publication 2: Vertigo and dizziness cause considerable more health care 
resource use and costs - results from the KORA FF4 study 
In this cross-sectional study, data from the German Cooperative Health Research 
in the Augsburg Region (KORA) FF4 study was used. The KORA FF4 study is the 14-
year follow-up of the KORA S4 study, and it is a population-based health survey 
conducted in the city of Augsburg and two surrounding counties with 2279 participants. 
The study was approved by the ethics committee of the Bavarian Chamber of 
Physicians, Munich (FF4: EC No. 06068).  
Eight health care cost components were measured to reflect the direct economic 
burden of vertigo, namely doctor consultations, outpatient hospital visits, inpatient 
hospital days, days in the intensive care unit (ICU), days in rehabilitation, alternative 
practitioner consultations, physiotherapy sessions, and drug utilization. Standardized 
unit prices were assigned to each cost component (see Appendix Table 1 of publication 
2) (Bock, Brettschneider et al. 2015). To assess the indirect economic burden of disease 
by asking gainfully employed participants the question: “How many days have you 
been unable to work for the last 12 months because of illness?” An average calendar 
day labour cost was used to calculate the monetary burden due to sick leave (Krauth, 
Buser et al. 2002, Bundesamt 2013). A social perspective was taken to report all the 
costs. No discount was considered since the cost data was collected within a single year.  
Two questions were used to assess the presence of disease exposure, namely “Have 
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you ever had vertigo or dizziness?” and “During the last 12 months, have you had 
vertigo or dizziness?” 
Considering the Andersen health care utilization model (Andersen and Newman 
1973) and the risk factors previously described which could affect the disease, sixteen 
covariates were included. They were six predisposing factors (namely age, gender, 
family status, education level, present job status, physical activity), two enabling factors 
(namely personal monthly income and health insurance type) and eight comorbidities, 
respectively. 
Since the cost data were skewed, with considerable zero values and outliers, a 
hurdle model (also known as two-part model) was applied to examine the relationship 
between exposure and cost outcome. IBM SPSS Statistics for Windows Version 20.0 
(Armonk, NY: IBM Corp.) was used for the descriptive tables, and R version 3.3.2 was 
used to calculate the hurdle model (RCore 2016). 
The doctoral candidate was the first author of this publication and primarily 
responsible for the conception and the analysis, as well as for the preparation of the 
manuscript with the guidance of Dr. Ralf Strobl and Prof. Eva Grill. This article was 
submitted on 01 March 2019 and accepted on 15 May 2019 by The Journal of 
Neurology after a single revision. The impact factor of the journal at this time was 4.204 
in the year of 2019. 
 
4. Results 
In the following section each research question is answered based on the results of 
the two studies: 
Within the three databases, 154 original papers were identified and 16 were 
included in our final systematic analysis. All 16 studies from seven countries presented 
partial economic evaluation referring to different diagnostic classification of vertigo, 
among which nine studies presented monetised cost results and seven studies reported 
health care utilisation. The median quality score of selected studies was six out of 19 
total from the Consensus on Health Economic Criteria (CHEC). Repeated and poorly 
targeted consultations at all levels of health care practitioners, excessive use of 
diagnostic imaging, and/or of emergency care accounted for the main reasons of high 
direct cost of vertigo. Disease related sick leave and low workload as well as 
comorbidity were reported to produce considerable social economic burden. Different 
10 
 
disease severity levels (Benecke, Agus et al. 2013), diagnosis types and setting 
(Neuhauser, Radtke et al. 2008, Benecke, Agus et al. 2013, Saber Tehrani, Coughlan et 
al. 2013, Grill, Strupp et al. 2014, Sun, Ward et al. 2014) may influence the cost and 
health care utilization. 
From the analysis of KORA FF4 data, 570 (25.0%) participants reported to have 
had moderate or severe dizziness or vertigo at least one time within the last 12 months. 
Evidences could be found that people with vertigo had a bigger economic burden than 
people without vertigo. Their total health care cost in the last 12 months per person was 
2641.9 Euro to 1902.9 Euro, SD=4786.2 and 5944.1, respectively. Among the cost 
difference of 739 Euro between two groups, the direct cost of consultation fee 
(especially at primary care physicians) accounted for the largest percentage with 177.2 
Euro (461.8 to 284.6, p<0.01). Indirect cost due to sick leave among all the gainfully 
employed participants with vertigo was 920.9 Euro (SD=2111.2) per person, and the 
average duration of sick leave was 7.5 days (SD = 17.2). After adjusting for covariates, 
presence of vertigo still increased both the probability of having any health care costs 
(OR=1.7, 95%CI= [1.2;2.4]) and the amount of health care costs (exp(β)=1.2, 95%CI= 
[1.1;1.4]). The analysis of cost determinants among two groups showed that private 
insurance and a medium level of education decreased the probability of having any 
health care costs. Determents analysis among participants with vertigo showed that two 
individual factors could affect the cost. The probability of having any cost was 
significantly decreased by having private insurance and increased by higher income. 
 
5. Discussion and conclusions 
According to the results of both the cross sectional study and the systematic review, 
vertigo and dizziness were common complaints with a high prevalence and incidence 
(Neuhauser, Radtke et al. 2008) in both primary care and hospital care system, which 
was also in line with other relevant literatures(Davis and Moorjani 2003, Neuhauser 
2007, Wiltink, Tschan et al. 2009) 
To the best of our knowledge, this is the first systematic review of the existing 
evidence of the economic burden of vertigo. Referring to our findings in the review, the 
current evidences for economic burden of vertigo and dizziness were limited. They did 
not cover the comprehensive assessment of the economic burden and the quality of 
studies was mostly mediocre. However, the exiting evidences still proved that the 
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presence of vertigo/dizziness consumed considerable health care resources and could 
bring quite a large amount of either direct (Neuhauser, Radtke et al. 2008, Wiltink, 
Tschan et al. 2009, Ahsan, Syamal et al. 2013, Benecke, Agus et al. 2013, Saber Tehrani, 
Coughlan et al. 2013, Grill, Strupp et al. 2014, Sun, Ward et al. 2014, Gandolfi, Reilly 
et al. 2015, McDowell and Moore 2016, Ammar, Govindu et al. 2017) or indirect 
economic burden (Neuhauser, Radtke et al. 2008, Wiltink, Tschan et al. 2009, Benecke, 
Agus et al. 2013, Sun, Ward et al. 2014) to patient, health care system and the whole 
society. Furthermore, the lack of conclusive evidence revealed apparent targets for 
future research. Future economic evaluation shall address the main cost drivers detected 
above, where evidence-based vertigo management may curb the increasing direct costs 
by improving the quality of care. These results are further confirmed by the COI study. 
With the findings from the KORA FF4 study, it could be shown that in the general 
population persons who reported at least one relevant episode of vertigo or dizziness 
during the last 12 months had significantly higher health care costs across almost all 
cost components. Another notable point is that the cross-sectional study found excess 
costs caused by medical consultation (especially in the primary care system) and 
emergency care services, which is just in line with current knowledge (Kerber, Meurer 
et al. 2008, Ahsan, Syamal et al. 2013) and our systematic review. Benecke et al. found 
in their study (Benecke, Agus et al. 2013) that, from 13 countries, 63.3% of persons 
with vertigo had lost working days during the three months preceding the baseline visit 
which confirms our indirect cost results.  
Based on the above findings and current literatures, there are many methods worth 
trying to control the rising cost of vertigo. Since inappropriate or unnecessary 
diagnostic tests and examinations lead to waste of medical resources (Neuhauser, 
Radtke et al. 2008, Grill, Strupp et al. 2014), it is highly recommended that health care 
givers pay attention to the effectiveness of imaging and avoid overuse. As the cost and 
health care utilization may varied from different diagnose types (Neuhauser, Radtke et 
al. 2008, Benecke, Agus et al. 2013, Saber Tehrani, Coughlan et al. 2013, Grill, Strupp 
et al. 2014, Sun, Ward et al. 2014), so health care givers should notice that these 
differences and diagnostic pathways should be assessed; more strict and practical 
guidelines should be developed for physicians(Ahsan, Syamal et al. 2013, Grill, Strupp 
et al. 2014, Ammar, Govindu et al. 2017). Since it was mentioned that the frequency of 
specialist consultation was high and only half of the vertigo patients were seen by 
primary care doctors (Neuhauser, Radtke et al. 2008), training and education of primary 
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care givers might also be a suggestion to reduce unnecessary treatment and 
medication(Grill, Strupp et al. 2014, Ammar, Govindu et al. 2017).  
To sum up, vertigo and dizziness are common in both the primary care and hospital 
care system and consume considerable health care resources and costs. Directed cost, 
such as diagnosis cost, medical consultation cost and emergency visit cost, largely 
contribute to the economic burden of vertigo. Indirect cost should also receive more 
attention since dizziness and vertigo could lead to a severe decrease in productivity of 
the working-age group. Evidence-based vertigo management may help to curb the 
increasing costs by improving the quality of care, thus reducing the long-term impact 
of vertigo. Further researches should be carried out to control the rising cost of vertigo.  
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6. Summary of both articles 
Vertigo is a common reason for medical consultations, and its diagnosis and 
treatment consume considerable medical resources. However, there is limited 
information on the specific cost of vertigo currently available. Therefore, the objective 
of both studies is to analyse the economic cost of vertigo. 
In the first publication, we aimed to target and summarise the existing evidence 
from available quantitative researches through a systematic review. All original studies 
about different kinds of vestibular diseases including unspecified vertigo published in 
the past ten years about economic evaluation of vertigo in developed countries were 
considered eligible. By searching three databases (PubMed, Embase, and Cochrane), 
154 studies were identified and 16 were finally qualified for inclusion after screening 
the abstracts and reading the full texts. Nine studies reported monetised results while 
seven offered health care utilization information. These studies showed that 
considerable costs were spent on diagnostic imaging, emergency care, and repeated 
medical consultations. The increased indirect costs (mainly from sick leave) 
demonstrated that vertigo and dizziness had incurred non-negligible societal burden. 
In the second publication, a cross-sectional data from the KORA FF4 study in 2013 
was used to analyse the economic burden of vertigo and dizziness and examine which 
individual characteristics would affect the utilization of health care. The extent of 
vertigo and dizziness was assessed by a standardized question “During the last 12 
months, have you had vertigo or dizziness?”. Eight different cost components of health 
care utilization were recorded to show the outcome of direct costs, and sick leave 
information was collected to reflect the indirect cost. Considering the dispersion 
tendency of the cost data, a hurdle model was applied as a statistic approach. The results 
showed that, among 2,277 participants (mean age 60.8, 48.4% male), 570 (25%) people 
were reported to have had dizziness or vertigo in the last year, and it costed 818 Euros 
more on average than people without vertigo (2720.9 Euro to 1902.9 Euro, respectively). 
Moreover, vertigo was an independent predictor of health care resource utilization and 
related costs after adjusting for covariates. These findings confirmed that vertigo 
requires considerable health care resources and could create significantly more health 
care related costs in both primary and pertinent secondary health care. Establishing care 
pathways and streamlined management with primary care physicians as gatekeepers 
and decision makers would be a promising way to decrease the costs of disease.  
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7. Zusammenfassung beider Publikationen 
Schwindel und Benommenheit gehören zu den häufigsten Beschwerden mit denen 
sich Patienten beim Arzt vorstellen und dessen Diagnose und Behandlung verbraucht 
erhebliche medizinische Ressourcen. Derzeit sind nur begrenzt Informationen zu den 
spezifischen Kosten -von Schwindel verfügbar. Ziel dieser Arbeitest es daher, die 
direkten und indirekten Kosten von Schwindel zu analysieren. 
Das Ziel der ersten Veröffentlichung war, den derzeitigen Wissensstand aus 
verfügbaren, quantitativen Untersuchungen durch eine systematische 
Literaturrecherche zusammenzufassen. Eingeschlossen wurden alle in den letzten zehn 
Jahren veröffentlichten Originalstudien zu den ökonomischen und sozialen 
Auswirkungen von Schwindelerkrankungen. In drei Datenbanken (PubMed, Embase 
und Cochrane) wurden 154 Studien identifiziert. Nachdem die Zusammenfassungen 
und Volltexte gelesen wurden 16 schließlich in der Studie eingeschlossen. Neun Studien 
enthielten monetär-relevante Ergebnisse, und sieben Informationen zur 
Inanspruchnahme des Gesundheitswesens. Diese Studien zeigten, dass erhebliche 
Kosten für diagnostische Bildgebung, Notfallversorgung und wiederholte ärztliche 
Konsultationen aufgewendet wurden. Die hohen indirekten Kosten (hauptsächlich 
durch Krankheitstage) zeigten, dass Schwindel und Benommenheit eine nicht zu 
vernachlässigende gesellschaftliche Belastung darstellten. 
In der zweiten Publikation wurden anhand von Querschnittsdaten aus der 
deutschen KORA-FF4-Studie 2013 die direkten und indirekten Kosten durch 
Schwindel analysiert und untersucht. –Das Vorliegen von Schwindel wurde anhand 
einer standardisierten Frage beurteilt: „Hatten Sie in den letzten 12 Monaten 
Schwindelgefühle oder -Anfälle? “. Die Inanspruchnahme des Gesundheitswesens 
wurde in acht Kostenkomponente aufgeteilt, Unter Berücksichtigung der Verteilung 
von Kostendaten wurde ein Hurdle Modell als statistischer Ansatz angewendet. Die 
Ergebnisse zeigten, dass unter 2.277 Teilnehmern (mittleres Alter 60.8, 48.4% Männer) 
570 (25%) im letzten Jahr Schwindel hatten und durchschnittlich 818 Euro mehr Kosten 
verursachten als Menschen ohne (2720.9 Euro zu 1902.9 Euro). Darüber hinaus war 
Schwindel ein unabhängiger Prädiktor für die Inanspruchnahme der 
Gesundheitsversorgung und der damit verbundenen Kosten. Diese Ergebnisse 
bestätigten, dass Schwindel und Benommenheit erhebliche Ressourcen für die 
Gesundheitsversorgung verursachen; sowohl in der primären als auch in der sekundären 
15 
 
Gesundheitsversorgung. Um diese Kosten zu kontrollieren, könnten weitere 
Untersuchungen durchgeführt werden, um das optimierte Management von 
Schwindelpatienten im ambulanten Bereich zu untersuchen. 
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